Catherine B. Meador

Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models

Catherine A. Eberlein, Daniel Stetson, Aleksandra Markovets et al. · Cancer Research · 2015 · 300 citations · Full text

Medicine, Oncology, Pharmacology +17

Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center

Lauren A. Eberly, Aaron Richterman, Anne G. Beckett et al. · Circulation Heart Failure · 2019 · 186 citations · Full text

Public Health, Cardiology, Internal Medicine +17

MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma

Yu Qian, Ana Galán‐Cobo, Irene Guijarro et al. · Cancer Cell · 2023 · 178 citations · Full text

Medicine, Cancer Biology, Oncology +16

SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer

Eiki Ichihara, David Westover, Catherine B. Meador et al. · Cancer Research · 2017 · 143 citations

Medicine, Oncology, Pharmacology +17

Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse

Karinna Almodovar, Wade T. Iams, Catherine B. Meador et al. · Journal of Thoracic Oncology · 2017 · 137 citations · Full text

Medicine, Molecular Biology, Oncology +13